Dr. Vincenzo Micale, Ph.D.
Total number of publications: 95
2014
-
Structural and behavioural changes in a rodent developmental disruption model of schizophrenia
Year: 2014, type: Conference abstract
-
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis
PHARMACOLOGICAL RESEARCH, year: 2014, volume: 87, edition: September, DOI
-
Therapeutic Potential of Cannabinoids in Schizophrenia
Recent Patents on CNS Drug Discovery, year: 2014, volume: 9, edition: 1, DOI
2013
-
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression
European Journal of Pharmacology, year: 2013, volume: 719, edition: 1-3, DOI
-
Endocannabinoid system and mood disorders: Priming a target for new therapies
Pharmacology & Therapeutics, year: 2013, volume: 138, edition: 1, DOI
-
Lack of interaction of endocannabinoids and 5-HT3 neurotransmission in associative fear circuits of the amygdala: Evidence from electrophysiological and behavioural experiments
Brain Research, year: 2013, volume: 1527, edition: Aug, DOI
-
Leading compounds for the validation of animal models of psychopathology
CELL AND TISSUE RESEARCH, year: 2013, volume: 354, edition: 1, DOI
2012
-
Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant
International Journal of Neuropsychopharmacology, year: 2012, DOI
-
Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse model
NATURE COMMUNICATIONS, year: 2012, volume: 3, edition: 1031, DOI
-
Increased levels of conditioned fear and avoidance behavior coincide with 3 changes in phosphorylation of the protein kinase B (AKT) within the amygdala 4 in a mouse model of extremes in trait anxiety
Neurobiology of Learning and Memory, year: 2012, volume: 98, edition: 1, DOI